S&P 500 Rejects.

Stocks that got rejected from S&P 500 in 2024 | S&P 500 rejects

ILMN

Illumina, Inc. is a American biotechnology company, headquartered in San Diego, California. As summarized from Yahoo Finance (https://finance.yahoo.com/quote/ILMN/profile), here are key points about the company:

Company Profile:

Business Description:** Illumina, Inc. is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company's solutions serve a range of customers from academic and government research institutions to clinical research, genomics, and molecular diagnostics laboratories. Illumina's technologies enable a wide range of applications, including whole-genome sequencing, gene expression analysis, and non-invasive prenatal testing, among others.

Removal from S&P 500 in 2024:**

**[INVESTIGATIVE SUMMARY BASED ON COMMON REASONS FOR INDEX REMOVAL, AS SPECIFIC REASONS FOR ILLUMINA, INC.'S REMOVAL COULDN'T BE FOUND AS OF THE GIVEN DATE]**

Potential reasons for a company's removal from the S&P 500 index, which might apply to Illumina, Inc.'s situation (though the exact reason is not specified here due to lack of direct information), include:

Note:** For the most accurate and up-to-date information regarding Illumina, Inc.'s removal from the S&P 500 in 2024, including the specific reason, please refer to official announcements from S&P Dow Jones Indices or Illumina, Inc.'s corporate communications.


Rejects and Newcomers:


Rejects and Newcomers: